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Background: Surgery for Graves’ disease may be performed with the intent of preserving thyroid function (subtotal
thyroidectomy) or ablating thyroid function (total thyroidectomy). This study examines the evolving practice in a
specialist endocrine surgical unit.
Method: Longitudinal cohort study of patients undergoing surgery for Graves’ disease between 1986 and 2008.
Outcome measures were thyroid failure, recurrent toxicity, recurrent laryngeal nerve (RLN) palsy, early reoperation
and hypocalcaemia. Time to thyroid failure was analysed by potential predictors.
Results: Of 149 patients (129 female), 78 (52.3 percent) underwent subtotal thyroidectomy with the intention to
preserve function (PF) and 71 (47.6 percent) total thyroidectomy with the intention to ablate thyroid function (AF).
Mean duration of follow-up was 11.1 years; 14.8 years and 7.0 years respectively. Of 78 PF procedures: six
(7.7 percent) patients suffered recurrent toxicity; 68 (87.2 percent) developed thyroid failure (four after treatment for
recurrent toxicity); and eight (10 percent) remained euthyroid without replacement. Male gender and remnant
gland weight were significant predictors of failure (P = 0.021 and 0.022 respectively). One patient developed
permanent RLN palsy and one permanent hypocalcaemia. Of 71 AF procedures: one developed acute airway
obstruction; one permanent RLN palsy; four permanent hypocalcaemia; and none developed recurrent toxicity.
There were no deaths within a year of surgery. There was no statistically significant difference in complication rates.
Conclusion: Most PF resections resulted in eventual thyroid failure. The shift to ablative surgery virtually eliminated
the need for lifelong specialist follow-up, albeit with an insignificant rise in permanent hypocalcaemia.
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Graves’ disease is the most common cause of hyper-
thyroidism affecting 0.5 percent of the population with a
marked female preponderance [1]. There remains no
consensus on the optimal management for patients with
Graves’ disease. In contrast to practice in the United States,
antithyroid medication rather than radio-active iodine is
recommended as first line treatment in the UK and Europe
[2]. Primary surgical management is uncommon and
referral usually follows failure of medical therapy and* Correspondence: zhk@abdn.ac.uk
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distribution, and reproduction in any mediumradioiodine ablation or for specific indications including
patient preference, pregnancy, and severe eye disease [2-4].
Surgery is effective in the management of patients with
Graves’ disease. It provides rapid control of hyperthyroi-
dism and a high cure rate [3,5]. Two surgical options are
available: subtotal thyroid resection aiming to preserve
thyroid function and total thyroidectomy to ablate thyroid
function eliminating the risk of recurrent toxicity and
reoperation [3]. Before 1992, the policy in Aberdeen
was to preserve thyroid function. Operations comprised
subtotal thyroid resection preserving a thyroid remnant
judged sufficient to permit recovery of normal thyroid
function (bilateral subtotal lobectomy or lobectomy andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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After 1992, total thyroidectomy was progressively adopted
becoming the operation of choice in 1999 (Figure 1).
Although total thyroidectomy has been associated with
increased risk of complications [6], with increasing ex-
perience and better training, total thyroidectomy can be
performed safely [7]. This study was designed to explore
the impact of this change in policy on clinical outcome.
Methods
This is a longitudinal cohort study of patients undergoing
surgery for Graves’ disease in Aberdeen. Patients were
under the care of two consultant surgeons with an interest
in endocrine surgery. Data were collected prospectively on
all patients between January 1986 and July 2008.
Surgical intervention was categorised according to the
intention of the procedure whether to preserve (PF) or
ablate thyroid function (AF). If the intent was to pre-
serve function options included subtotal thyroidectomy
or Dunhill Procedure. If ablation of function was the
goal, total thyroidectomy or Dunhill procedure was used.
Dunhill procedures were performed to preserve or ablate
function depending on remnant size. On occasion a
small remnant, insufficient to maintain euthyroidism,
was preserved to protect the parathyroid glands. All pa-
tients were prepared for surgery using combinations of
antithyroid drugs, beta-blockers and Lugol’s iodine.
Surgery was performed using the conventional tech-
nique [8]. The recurrent laryngeal nerve (RLN) was
always identified and exposed. An attempt to identify
and preserve all parathyroid glands was routine. The in-
ferior thyroid artery was not routinely ligated to preserve
parathyroid blood supply. If a gland was devascularised
it was auto-transplanted in the sternomastoid muscle.Figure 1 Trends in surgery over time by type of thyroidectomy,
1986–2008. Dunhill procedure (lobectomy and subtotal lobectomy),
depending on remnant size, was used for both preservation and
ablation of function.During subtotal thyroidectomy, a large remnant (9–10
grams) was left if gland weight was judged to be more
than 50 grams and a small remnant (2–4 grams) if less
than 50 grams.
Follow-up
All patients were reviewed at 1 month and then 6 monthly
until euthyroid and normocalcaemic. Thereafter patients
were registered on the Grampian Automated Thyroid
Register (GAFUR) for automated biochemical and primary
care review with recall to the endocrine service in the
event of thyroid failure or relapse. Laryngoscopy was not
routine until 2000 and only patients with voice change
underwent laryngoscopy before this date.
Outcomes
Outcome measures were thyroid failure, recurrent
toxicity, RLN palsy, early reoperation and hypocalcaemia.
Clinical thyroid failure was defined as clinical and
biochemical evidence of hypothyroidism requiring thy-
roxine replacement. For patients undergoing surgery
intended to preserve function, the time to thyroid failure
was analysed by potential predictors. When ablative
surgery was performed thyroxine replacement was com-
menced immediately. Recurrent toxicity was defined as
clinical and biochemical evidence of thyrotoxicosis. Thy-
roid stimulating antibody (TSAb) measurements only
became available later in the study.
Statistical analysis
The Kaplan-Meier method was used to study the tem-
poral relationship between surgery and thyroid failure
and recurrent toxicity. Univariate analyses were
performed using Fisher’s exact, Mann–Whitney U and
log rank tests. A Cox regression analysis examined
the potential association between baseline variables
(including age, gender, resected and remnant weight)
and subsequent thyroid failure. The likelihood ratios
(LR) backward stepwise method was used with an
entry criterion of P < 0.05 and a removal criterion of
P > 0.10. P < 0.05 was considered statistically signifi-
cant. Logistic regression was used to assess predictors
of hypocalcaemia. Data were analysed using SPSS for
Windows version 16.0 (SPSS, Chicago, Illinois, USA).
Results
Demographics and baseline characteristics
Between 1986 and 2008, there was a gradual reduction in
the number of operations performed and a total of 149
patients underwent surgery for Graves’ disease (Figure 1).
Patients comprised 129 females (86.5 percent) and 20
males (13.4 percent) with a median age of 30 years (Inter-
quartile range (IQR) 20–34, range 12–65 years) (Table 1).
Of 149 patients, 10 (6.7 percent) were referred for surgery







Age, median (range), years 27 (17–54) 32 (12–65)
Female 66 (84.6) 63 (88.7)
Indication(s) for surgery* Relapse 32 (41.0) 32 (45.1)
Inadequate control of thyrotoxicosis 18 (23.1) 35 (49.3)
Patient preference 8 (10.3) 19 (26.8)
Poor compliance with ATD 15 (19.2) 7 (9.9)
Large goitre 7 (9.0) 5 (7.0)
Severe thyroid eye disease 1 (1.3) 3 (4.2)
Other** 5 (6.4) 12 (16.9)
Operation Subtotal thyroidectomy or Dunhill procedure 78 (100.0) 18 (25.4)
Total thyroidectomy NA 53 (74.6)
Gland weight Total gland weight, mean (IQR), grams 62 (46–78) 50 (37–64)
Remnant gland weight, mean (IQR), grams 7 (5–8 ) 1 (0–1)
Resected gland weight, mean (IQR), grams 55 (42–70) 50 (36–64)
Proportion of gland resected (%) 90 (88–92) 100 (98–100)
Follow-up, mean (IQR), years 14.8 (12.1–19.4) 7.0 (3.2–10.8)
Values in parentheses are percentages unless otherwise indicated. NA not applicable. ATD antithyroid drugs. IQR Interquartile range. *Some patients fulfilled more
than one indication for surgery. ** Pregnancy, adverse drug reactions and failure of radioiodine.
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preference (50 percent) was the commonest indication for
this approach. One hundred and thirty-nine patients (93.3
percent) were referred after a trial of one or more courses
of antithyroid drugs. In these patients relapse (46.0 per-
cent), inadequate control of thyrotoxicosis (38.1 percent)
and patient preference (10.8 percent) were the commonest
indications for surgical referral.
Of 149 patients, 73 (49.0 percent) underwent a sub-
total thyroidectomy, 23 (15.4 percent) a Dunhill pro-
cedure, and 53 (35.6 percent) a total thyroidectomy
(Table 1). In 78 patients (52.3 percent) the intent was to
preserve normal function (PF group). In the remaining
71 patients (47.7 percent) the intent was to ablate func-
tion with immediate thyroxine replacement (AF group).
Mean duration of follow-up was 11.7 years (IQR 4.7 to
16.9 years, range 0.1 to 22.5 years). There was no differ-
ence in gender distribution between the two groups
(Table 1). The estimated total gland weight ranged from
10 to 240 g (median 57 g, IQR 41–74 g) (Table 1). Histo-
logically, all 149 specimens showed evidence of Graves’
disease and one (0.7 percent) specimen an incidental pap-
illary carcinoma greater than 1 cm.
Time to failure with PF surgery
Of the 78 patients undergoing PF surgery, 66 (84.6
percent) were female and 12 (15.4 percent) were male.
Sixty-eight (87.2 percent) were subsequently commencedon thyroxine replacement (Figure 2 Additional file 1:
Table S1); four (5.1 percent) of them after radioiodine
treatment for recurrent toxicity.
On Cox regression analysis, gender (P = 0.021) and
remnant weight (P = 0.022) were independent predictors
of thyroid failure with hazard ratios of 2.197 and 0.713
respectively. Males were associated with a significantly
higher rate of failure over time (Figure 2 Additional file 1:
Table S1). Age at operation (P = 0.593), duration of
diagnosis prior to surgery (P = 0.668), resected weight
(P = 0.298) and percentage of gland resected (P = 0.267)
did not significantly predict thyroid failure.
At five years, a higher rate of thyroid failure was
observed in patients under 30 years; however, at subse-
quent follow-up beyond five years, no difference was
observed (X2 = 0.03, P = 0.874; log rank test). When
compared with glands weighing more than 50 grams, pa-
tients with glands of 50 grams or less were more likely
to develop thyroid failure earlier over time (X2 = 6.76,
P = 0.009; log rank test).
Resected specimens were routinely examined for evi-
dence of lymphocytic infiltration. Lymphocytic infiltration
was ‘absent’ or not noted in 46 (59.0 percent) specimens,
‘minimal’ in 21 (26.9 percent) specimens, and ‘marked’ in
11 (14.1 percent) specimens. Although not statistically
significance (X2 = 3.57, P = 0.059; log rank test), a higher
rate of early failure was observed in patients with ‘marked’
lymphocytic infiltration.
Figure 2 Time to thyroid failure after PF surgery by sex.
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Of the 78 PF operations, six (7.7 percent), all female,
developed recurrent toxicity; 3 at one year, 5 at five
years and 6 at 11 years. Recurrence was treated with
radioactive iodine and antithyroid drugs. Although
not statistically significant, recurrent toxicity was
commoner among patients over 30 years (3 of 20
versus 3 of 58; X2 = 1.86, P = 0.173), total gland
weights over 50 grams (5 of 55 versus 1 of 23; X2 = 0.58,
P = 0.448), and gland resections of 90 percent or
less (4 of 40 versus 2 of 38; X2 = 0.50, P = 0.479).
Recurrence was not encountered in patients undergoing




Acute airway obstruction** 0 (0
Subcutaneous haematoma 1 (1
Transient RLN palsy† 1 (1
Permanent RLN palsy† 1 (1
Permanent hypocalcaemia†† 1 (1
Wound infection 4 (5
Wound seroma 0 (0
Total hospital stay, mean (SD) (median), days 3.30 (1.4
Recovery time, mean (SD) (median), days 2.83 (1.4
Values in parentheses are percentages unless specified. RLN, recurrent laryngeal ne
* Fisher’s exact test unless specified.
** Airway obstruction due to deep tension haematoma.
† Laryngoscopy was not routine until 2000 and only patients with voice change un
†† Relative risk (95% CI) comparing intention to ablate with intention to preserve =
‡Mann–Whitney U test.Morbidity
There were no deaths within a year of surgery. One
patient (0.7 percent) developed acute airway obstruc-
tion requiring urgent evacuation of haematoma
(Table 2). Seven (4.7 percent) patients had recurrent
laryngeal nerve (RLN) palsy confirmed by laryngos-
copy; two (1.3 percent) of them permanent as a result
of intraoperative injury or traction. None developed
bilateral palsy. The most common early complication
was transient hypocalcaemia (serum calcium less than
2.2 mmol/l) occurring in 87 (58.4 percent) patients;
highest after total thyroidectomy (84.9 percent)
followed by the Dunhill procedure (65.2 percent) and
subtotal thyroidectomy (37.0 percent). Hypocalcaemia
was permanent in 5 (3.4 percent) patients; highest
after total thyroidectomy (7.5 percent) and lowest
after Dunhill procedure (0.0 percent). Crude analyses
revealed an increased risk of transient hypocalcaemia
with total thyroidectomy (Table 3). On logistic regres-
sion analysis, the type of thyroidectomy constituted
an independent risk factor for transient but not per-
manent hypocalcaemia. Age, gender and number of
parathyroid glands seen, preserved or reimplanted did
not affect the onset of transient or permanent
hypocalcaemia.
Table 2 stratifies complications by operative intent.
Total hospital stay and recovery time (time from oper-
ation to discharge) were significantly shorter for patients
undergoing ablative surgery (P = 0.003 and 0.005 re-
spectively; Mann–Whitney U test) (Table 2). The differ-
ence in length of hospital stay is likely to reflect a





(%) No. (%) P value*
.0) 1 (1.4) 0.477
.3) 1 (1.4) 1.000
.3) 4 (5.6) 0.192
.3) 1 (1.9) 1.000
.3) 4 (5.6) 0.192
.1) 2 (2.8) 0.683
.0) 1 (1.4) 0.477
3) (3.0) 2.18 (1.11) (2.0) 0.003‡
4) (2.0) 1.87 (1.43) (1.0) 0.005‡
rve.
derwent laryngoscopy before this date.
4.39 (0.50–38.9).
Table 3 Rates of postoperative hypocalcaemia
No./total (%) Relative risk (95% CI)*
Hypocalcaemia, transient or permanent
Subtotal thyroidectomy or Dunhill procedure 43/96 (44.8) 1 [Reference]
Total thyroidectomy 49/53 (92.5) 2.06 (1.63–2.61)
Transient hypocalcaemia
Subtotal thyroidectomy or Dunhill procedure 42/73 (43.8) 1 [Reference]
Total thyroidectomy 45/53 (84.9) 1.94 (1.51–2.50)
Permanent hypocalcaemia
Subtotal thyroidectomy or Dunhill procedure 1/96 (1.0) 1 [Reference]
Total thyroidectomy 4/53 (7.5) 7.26 (0.83–63.17)
Values in parentheses are percentages.
* Relative risks compare total thyroidectomy with subtotal thyroid resection (subtotal thyroidectomy or Dunhill procedure).
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The management of Graves’ disease aims to control
hyperthyroidism and restore euthyroidism. With the
advent of radioiodine ablation, a gradual reduction in
the rate of surgery was observed. In 1972, Michie et al.
[9] reported an annual rate of 56 operations for
thyrotoxoicosis in Aberdeen. By 1987, Cusick et al. [4]
reported 16 operations per annum and in 1999 this de-
clined to 8 operations per annum [10]. This trend con-
tinues despite an apparently stable incidence of disease.
The commonest indications for surgery were inad-
equate control or repeated relapse. The aim of surgery
in Graves’ disease is to provide a rapid and permanent
means of controlling hyperthyroidsim. Subtotal thyroid-
ectomy was the standard treatment for Graves’ disease
for most of the twentieth century. This approach aims to
restore function and reduce complications by preserving a
remnant of thyroid tissue [6,11]. Palit et al. [5] reported
that subtotal thyroidectomy achieved euthyroidism in 60
percent of patients and supported its use in milder forms
of hyperthyroidism.
Before 1992, the surgical policy in Aberdeen was to
perform subtotal resections with a view to preserving
thyroid function. Such policy was based on previous
experience suggesting higher rates of thyroid failure with
smaller remnants [9]. Subsequent evidence [4] revealed
that recurrence was greatest in small glands. After 1992,
smaller remnants of 2–4 grams were preserved in small
glands to avoid recurrent toxicity albeit at the cost of a
higher rate of thyroid failure; and larger remnants of 9–10
grams in large glands to avoid thyroid failure. As practice
evolved, and considering published evidence, the policy
moved towards routine total thyroidectomy (Figure 1).
There are only two prospective randomised studies
[6,12] comparing total and subtotal thyroid resection
and neither followed consolidated standards of reporting
trials (CONSORT). Both studies focused primarily on
the impact of surgery on thyroid eye disease and con-
cluded subtotal resection was the optimum procedure.Although early complication rates were provided, max-
imum follow-up times were under five years. The inci-
dence of thyroid failure following subtotal resection was
not investigated or relevant because small remnants were
preserved with the intent of ablating function. The present
study represents the first in-depth prospective analysis of
time to thyroid failure following subtotal resection with
the intent to preserve function. This long-term study
demonstrates that thyroid failure can occur at 22 years
and recurrent toxicity beyond 10 years.
A myriad of factors including remnant weight, degree
of lymphocytic infiltration, and thyroid stimulating hor-
mone receptor, thyroid peroxidase or antithyroglobulin
antibodies for their value in predicting function after
subtotal thyroidectomy [2,4,9,11,13,14]. Most studies
concluded that remnant gland weight is the most con-
sistent risk factor. This study investigated the incidence
of thyroid failure over time in patients undergoing
surgery intended to preserve thyroid function (mainly
subtotal thyroidectomy). The prevalence of thyroid
failure in this cohort exceeds other prevalence estimates
although this may be related to the length of follow-up
[5,11,14]. Female patients and those with higher remnant
weights demonstrated longer periods of euthyroidism
but the majority developed clinical thyroid failure within
the first decade. Our finding that gender and the amount
of residual tissue influence the risk of failure supports
previously published data [4,5,11]. However in contrast
to previous studies [4,11], the relationship between age
and thyroid failure was not statistically significant.
Recurrent toxicity is a more significant complication
than thyroid failure which can almost be considered the
end point in most patients. Although early complication
rates after operations to preserve function are minimal,
there is a risk of recurrence. Reoperations are technically
more difficult and carry higher risks of morbidity as a
result [15]. This study had a recurrence rate of 7.7 per-
cent with the majority in the five years following surgery.
PF operations increase the risk of undetected hypo or
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follow-up [14].
After the introduction of total thyroidectomy, the risk
of recurrent toxicity was eliminated sparing complica-
tions of reoperation and radioiodine ablation [1,15].
Total thyroidectomy coupled with immediate thyroxine
replacement achieves a rapid and permanent return of
euthyroidism. A recent study from the United States
[16] showed that total thyroidectomy is more cost-
effective than radioiodine or lifelong antithyroid medi-
cation in patients failing to achieve euthyroidism after
18 months of medical treatment by avoiding the need
for lifelong surveillance.
Hypocalcaemia and recurrent laryngeal nerve (RLN)
palsy are well recognised complications of thyroid and
parathyroid surgery. Previous studies have presented
comparable complication rates between subtotal thyroid-
ectomy and total thyroidectomy in Graves’ disease [2].
In a meta-analysis of 35 clinical studies between 1965
and 1998, Palit et al. [5] reported no significant differ-
ence in the rate of either permanent recurrent laryngeal
nerve palsy (0.7 percent of subtotal thyroidectomy and
0.9 percent of total thyroidectomy) or permanent hypo-
calcaemia (1.0 and 0.9 percent respectively) between
subtotal and total thyroidectomy.
Ablative surgery exposed patients to a significantly
higher rate of transient, but not permanent, compli-
cations. In an analysis of 5846 patients undergoing
bilateral thyroid surgery, Thomusch et al. [17] identified
Graves’ disease, total thyroidectomy, bilateral central
ligation of the inferior thyroid artery, and identification
and preservation of no or only a single parathyroid gland
as independent risk factors for permanent hypocalcae-
mia. Our study concluded an overall incidence of 58.4
percent for transient hypocalcaemia increasing signifi-
cantly with more extensive resections. The overall occur-
rence of permanent hypocalcaemia was 3.4 percent; this
was more frequently observed with total thyroidectomy
but statistically insignificant. However, given the small
sample size in this study, the possibility of a type II error
cannot be excluded.
RLN palsy, mainly transient, is the second most com-
mon complication following thyroid surgery. The inci-
dence varies depending on the underlying disease, the
extent of resection, whether first-time or reoperation,
and the surgical experience and technique [18,19]. Rou-
tine RLN identification was performed in all patients.
The third national audit of the British Association of
Endocrine and Thyroid Surgeons (BAETS) documented
an overall RLN palsy rate of 2.5 percent for first-time
operations [20]. Studies in Graves’ disease however, have
reported rates of permanent palsy ranging from 0 per-
cent to as high as 4.5 percent [4,21]. In this study, per-
manent RLN palsy occurred in 2 (1.3 percent) patientswith no significant difference between groups. Laryngos-
copy was not routine prior to 2000 and only undertaken
in the presence of voice change; it is therefore possible
that a permanent palsy could have been overlooked.
It is known that resected specimens from patients with
Graves’ disease exhibit an increased incidence of inciden-
tal carcinomas [22]. When collating many studies, Palit
and colleagues [5] reported a rate of 4.5 percent. However,
despite a worldwide increase in thyroid cancer and re-
gional trends of advanced disease [23], the incidence of
carcinoma greater than 1cm, in this cohort was low (0.7
percent) in spite of careful review by a dedicated patholo-
gist in a multidisciplinary setting. Microcancers were not
recorded in the prospective database.
The strengths of this study include its prospective de-
sign and long duration of follow-up. All patients were
under the care of only two consultant surgeons reducing
perioperative variability. The limitations of this study in-
clude a relatively small sample size with the possibility of a
Type II error and its nonrandomised nature with the like-
lihood of selection bias. However, since the study moni-
tors the effect of a known change in surgical practice on
all patients, the degree of selection bias is minimal.
The perceived advantages of subtotal thyroidectomy
were reduced complication rate and possibility of main-
taining euthyroidism. However this study concurs with
the growing evidence that complications of total thyroid-
ectomy are no different and subsequent management is
greatly simplified. With prolonged follow-up it is clear
that thyroid failure is likely in the majority of patients
treated surgically and the primary goal of treatment
should change from avoidance of hypothyroidism to pre-
vention of recurrence.
Conclusions
Results support previous studies demonstrating low com-
plication rates with thyroid surgery. The majority under-
going PF resections eventually developed thyroid failure.
AF resections eliminate the need for lifelong specialist
follow-up by abolishing the risk of recurrent toxicity and
undetected hypothyroidism, albeit with an insignificant
rise in permanent hypocalcaemia.
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